ClosedPublished 27 Apr 2023

Abbott Laboratories /
Cardiovascular Systems, Inc.

Abbott Laboratories completes acquisition of Cardiovascular Systems, Inc.

Price
$850m
Stage
Closed
Buy side: Abbott Laboratories
Buy sideAbbott Laboratories
Target: Cardiovascular Systems, Inc.
TargetCardiovascular Systems, Inc.
Source · 27 Apr 2023
Buy side: Abbott Laboratories
Buy sideAbbott Laboratories
Target: Cardiovascular Systems, Inc.
TargetCardiovascular Systems, Inc.
01 / BuyerAbbott Laboratories
02 / TargetCardiovascular Systems, Inc.
01

What happened

Abbott Laboratories acquired Cardiovascular Systems, Inc. on April 27, 2023, through a merger that made Cardiovascular Systems, Inc. a subsidiary of Abbott.

The aggregate consideration was approximately $850 million.

02

The source

Everything on this page comes from the source below.

01
Source · Original source

Abbott Laboratories completes acquisition of Cardiovascular Systems, Inc.

This document is the source for the companies, stage, figure and people on this page.

Original filingUnlock with Pro
03

Timeline

Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.

  1. Closed

    The source this page is built from.

  2. Published by the source

    The source this page is built from.

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Request accessAlready invited? Sign in

Carrywatch Pro is by invitation. An invite lets you buy Pro.